Table 3.
Demographic and clinical manifestations of patients with retinal artery occlusion.
| Author, Month, Year | Study Design | Location Country | Age, Gender | Total Patients | Diagnosis | COVID Status | Biochemistry | Comorbidity |
|---|---|---|---|---|---|---|---|---|
| Kulkarni MS et al [29], May, 2022 | Case report | India | 49, M 20, M |
2 | Choroidal artery occlusion Mixed CRAO + CRVO |
RT-PCR+ Hospitalization RT-PCR+ Hospitalization |
NA D-dimer: 321 ng/mL, C-reactive protein (CRP; 2.44 mg/dL), lactate dehydrogenase (LDH; 414 IU/L) |
NA NA |
| Acharya S et al [30], June, 2020 | Case report | USA | 60, M | 1 | CRAO | RT-PCR+ ICU |
D-dimer: 42.131 Fibrinogen: >700 C-reactive protein: 7.02 Ferritin: 324 Procalcitonin: 0.07 IL-6: 546.1 |
NA |
| Gascon P et al [31], May, 2020 |
Case report | France | 53, M | 1 | PAMM, AMN, deep retinal hemorrahages | RT-PCR+ Chest CT: bilateral ground glass opacities |
C-reactive protein: 29 mg/L thrombocytosis |
NA |
| Virgo P et al [32], June, 2020 |
Case report | UK | 37 32 |
2 | PAMM, AMN | RT-PCR+ IgG+ |
NA NA |
NA NA |
| Montesel A et al [33], Dec, 2020 |
Case report | Switzerland | 59, M | 1 | CRAO | RT-PCR+ ICU |
D-Dimer: 2059 ng/mL (normal <500 ng/mL); Fibrinogen: 5.9 g/L (normal 2.0–4.0 g/L); C-reactive protein: 184 mg/L (normal <10 mg/L); IL-6: 42 pg/dl (normal <11 pg/dL) |
Hypertension, hyperuricemia |
CRVO: central retina vein occlusion; CRAO: central retina artery occlusion; PAMM: paracentral acute middle maculopathy; AMN: acute macular neuroretinopathy; RT-PCR: real time polymerase chain reaction; IUC: intensive unit care; DVT: deep venous thrombosis; NA: not applicable; CRP: C-reactive protein; LDH: lactate dehydrogenase; IL-6: interleukin-6.